デフォルト表紙
市場調査レポート
商品コード
1378837

内分泌検査市場レポート:検査タイプ、技術、最終用途、地域別、2023-2028年

Endocrine Testing Market Report by Test Type, Technology, End Use, and Region 2023-2028

出版日: | 発行: IMARC | ページ情報: 英文 138 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.10円
内分泌検査市場レポート:検査タイプ、技術、最終用途、地域別、2023-2028年
出版日: 2023年11月02日
発行: IMARC
ページ情報: 英文 138 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

概要

世界の内分泌検査市場規模は2022年に104億米ドルに達しました。今後、IMARC Groupは、市場は2028年までに164億米ドルに達し、2022年から2028年の間に7.9%の成長率(CAGR)を示すと予測しています。

内分泌検査とは、体内のホルモンレベルを測定し、ホルモン関連疾患を診断するために行われる医療行為を指します。この検査は、特定の慢性疾患の発症につながる可能性のあるホルモン濃度の不均衡を検出するのに役立ちます。これらの疾患は通常、細針吸引(FNA)、超音波検査、コンピュータ断層撮影(CT)、磁気共鳴画像法(MRI)、陽電子放出検査(PET)、放射性ヨードスキャン(RAI)、静脈サンプリングなどで検査されます。このようにして得られた検査結果は、疾患の進行度を判定し、患者に提供されている治療の効果をモニターするのに役立ちます。

副腎不全、クッシング病、巨大症、甲状腺機能低下症、甲状腺機能亢進症などの内分泌関連疾患の有病率の増加は、市場の成長を促進する重要な要因の1つです。さらに、適時検査の利点に関する健康意識と意識の高まりが、市場の成長を後押ししています。定期的な検査は、特に高齢者において、合併症の発症や疾患の悪化のリスクを最小限に抑えます。これに伴い、老人人口の増加がもう一つの主要な成長促進要因として作用しています。さらに、コロナウイルス(COVID-19)の大流行が始まったため、感染患者の高血糖を検出するために内分泌検査が広く使用されるようになっています。さらに、ユーザーフレンドリーで費用対効果の高い在宅診断を容易にするバイオセンサーを搭載した、操作が簡単な革新的検査キットの開拓が、市場に明るい展望を生み出しています。ヘルスケアセンター、検査室、診断センターでは、高精度で正確な結果を提供するために、技術的に進歩した質量分析付き液体クロマトグラフィー(LC-MS)技術も使用されています。ヘルスケアインフラの改善など、その他の要因も市場をさらに牽引すると予想されます。

本レポートで扱う主な質問

  • 世界の内分泌検査市場はこれまでどのように推移し、今後数年間はどのように推移するのか?
  • COVID-19が世界の内分泌検査市場に与えた影響は?
  • 主要な地域市場は?
  • 検査タイプ別の市場内訳は?
  • 技術別の市場内訳は?
  • 最終用途に基づく市場内訳は?
  • 業界のバリューチェーンにおける様々な段階とは?
  • 業界の主要な促進要因と課題は何か?
  • 世界の内分泌検査市場の構造と主要プレーヤーは?
  • 業界の競合の程度は?

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界の内分泌検査市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳:検査タイプ別

  • 甲状腺検査
    • 市場動向
    • 市場予測
  • インスリン検査
    • 市場動向
    • 市場予測
  • ヒト絨毛性ゴナドトロピン検査
    • 市場動向
    • 市場予測
  • プロラクチン検査
    • 市場動向
    • 市場予測
  • 黄体形成ホルモン検査薬
    • 市場動向
    • 市場予測
  • プロゲステロン検査
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 市場内訳:技術別

  • イムノアッセイ
    • 市場動向
    • 市場予測
  • タンデム質量分析
    • 市場動向
    • 市場予測
  • センサー技術
    • 市場動向
    • 市場予測
  • LC-MS
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳:最終用途別

  • 病院
    • 市場動向
    • 市場予測
  • 外来医療センター
    • 市場動向
    • 市場予測
  • 臨床検査センター
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳:地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳:国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • Agilent Technologies Inc.
    • Bio-Rad Laboratories Inc.
    • BioMerieux SA
    • DiaSorin S.p.A.
    • F. Hoffmann-La Roche AG(Roche Holding AG)
    • Laboratory Corporation of America Holdings
    • Quest Diagnostics Incorporated
    • Siemens Healthineers AG(Siemens Aktiengesellschaft)
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: Endocrine Testing Market: Major Drivers and Challenges
  • Figure 2: Global: Endocrine Testing Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Endocrine Testing Market: Breakup by Test Type (in %), 2022
  • Figure 4: Global: Endocrine Testing Market: Breakup by Technology (in %), 2022
  • Figure 5: Global: Endocrine Testing Market: Breakup by End Use (in %), 2022
  • Figure 6: Global: Endocrine Testing Market: Breakup by Region (in %), 2022
  • Figure 7: Global: Endocrine Testing Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 8: Global: Endocrine Testing (Thyroid Test) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Endocrine Testing (Thyroid Test) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Endocrine Testing (Insulin Test) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Endocrine Testing (Insulin Test) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Endocrine Testing (Human Chorionic Gonadotropin Test) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Endocrine Testing (Human Chorionic Gonadotropin Test) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Endocrine Testing (Prolactin Test) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Endocrine Testing (Prolactin Test) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Endocrine Testing (Luteinizing Hormone Test) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Endocrine Testing (Luteinizing Hormone Test) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Endocrine Testing (Progesterone Test) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Endocrine Testing (Progesterone Test) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Endocrine Testing (Other Test Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Endocrine Testing (Other Test Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Endocrine Testing (Immunoassay) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Endocrine Testing (Immunoassay) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Endocrine Testing (Tandem Mass Spectroscopy) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Endocrine Testing (Tandem Mass Spectroscopy) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Endocrine Testing (Sensor Technology) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Endocrine Testing (Sensor Technology) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Endocrine Testing (LC-MS) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Endocrine Testing (LC-MS) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Endocrine Testing (Other Technologies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Endocrine Testing (Other Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Global: Endocrine Testing (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Global: Endocrine Testing (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Global: Endocrine Testing (Ambulatory Care Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Global: Endocrine Testing (Ambulatory Care Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Global: Endocrine Testing (Clinical Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Global: Endocrine Testing (Clinical Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Global: Endocrine Testing (Other End Uses) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Global: Endocrine Testing (Other End Uses) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: North America: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: North America: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: United States: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: United States: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Canada: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Canada: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Asia Pacific: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Asia Pacific: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: China: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: China: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Japan: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Japan: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: India: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: India: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: South Korea: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: South Korea: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Australia: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Australia: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Indonesia: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Indonesia: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Others: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Others: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Europe: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Europe: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Germany: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Germany: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: France: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: France: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: United Kingdom: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: United Kingdom: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Italy: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Italy: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Spain: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Spain: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Russia: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Russia: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Others: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Others: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Latin America: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: Latin America: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Brazil: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 81: Brazil: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 82: Mexico: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 83: Mexico: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 84: Others: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 85: Others: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 86: Middle East and Africa: Endocrine Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 87: Middle East and Africa: Endocrine Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 88: Global: Endocrine Testing Industry: SWOT Analysis
  • Figure 89: Global: Endocrine Testing Industry: Value Chain Analysis
  • Figure 90: Global: Endocrine Testing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Endocrine Testing Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Endocrine Testing Market Forecast: Breakup by Test Type (in Million US$), 2023-2028
  • Table 3: Global: Endocrine Testing Market Forecast: Breakup by Technology (in Million US$), 2023-2028
  • Table 4: Global: Endocrine Testing Market Forecast: Breakup by End Use (in Million US$), 2023-2028
  • Table 5: Global: Endocrine Testing Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Endocrine Testing Market Structure
  • Table 7: Global: Endocrine Testing Market: Key Players
目次
Product Code: SR112023A2900

Abstract

The global endocrine testing market size reached US$ 10.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 16.4 Billion by 2028, exhibiting a growth rate (CAGR) of 7.9% during 2022-2028.

Endocrine testing refers to the medical procedures conducted to measure the hormonal levels in the body and the diagnosis of hormone-related disorders. The testing aids in detecting an imbalance in the concentrations of hormones that may lead to the development of certain chronic conditions. These disorders are usually tested by fine-needle aspiration (FNA), ultrasound, computerized tomography (CT), magnetic resonance imaging (MRI), positron emission test (PET), radioactive iodine scan (RAI) and venous sampling. The test results thus obtained can assist in determining the progression of the disorder and monitoring the effects of the treatment being provided to the patient

The increasing prevalence of endocrine-related disorders, such as adrenal insufficiency, Cushing's disease, gigantism, hypothyroidism and hyperthyroidism, represents one of the key factors driving the growth of the market. Furthermore, the increasing health consciousness and awareness regarding the benefits of timely testing is providing a boost to the market growth. Periodic testing minimizes the risks of developing complications or aggravation of the disorder, especially in elderly patients. In line with this, the rising geriatric population is acting as another major growth-inducing factor. Moreover, due to the onset of the coronavirus (COVID-19) pandemic, endocrine testing is being widely used to detect hyperglycemia in infected patients. Additionally, the development of innovative easy-to-operate test kits equipped with biosensors that facilitate user-friendly and cost-effective home-based diagnosis is creating a positive outlook for the market. Healthcare centers, laboratories and diagnostic centers are also using technologically advanced liquid chromatography with mass spectrometry (LC-MS) techniques to provide highly precise and accurate results. Other factors, including improvements in the healthcare infrastructure, are anticipated to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global endocrine testing market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on test type, technology and end use.

Breakup by Test Type:

Thyroid Test

Insulin Test

Human Chorionic Gonadotropin Test

Prolactin Test

Luteinizing Hormone Test

Progesterone Test

Others

Breakup by Technology:

Immunoassay

Tandem Mass Spectroscopy

Sensor Technology

LC-MS

Others

Breakup by End Use:

Hospitals

Ambulatory Care Centers

Clinical Laboratories

Others

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Agilent Technologies Inc., Bio-Rad Laboratories Inc., BioMerieux SA, DiaSorin S.p.A., F. Hoffmann-La Roche AG (Roche Holding AG), Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Siemens Healthineers AG (Siemens Aktiengesellschaft) and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

  • How has the global endocrine testing market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global endocrine testing market?
  • What are the key regional markets?
  • What is the breakup of the market based on the test type?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the end use?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global endocrine testing market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Endocrine Testing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Test Type

  • 6.1 Thyroid Test
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Insulin Test
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Human Chorionic Gonadotropin Test
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Prolactin Test
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Luteinizing Hormone Test
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Progesterone Test
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Others
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Immunoassay
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Tandem Mass Spectroscopy
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Sensor Technology
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 LC-MS
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by End Use

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Care Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Clinical Laboratories
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Agilent Technologies Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Bio-Rad Laboratories Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 BioMerieux SA
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 DiaSorin S.p.A.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 F. Hoffmann-La Roche AG (Roche Holding AG)
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 SWOT Analysis
    • 14.3.7 Laboratory Corporation of America Holdings
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Quest Diagnostics Incorporated
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Siemens Healthineers AG (Siemens Aktiengesellschaft)
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Thermo Fisher Scientific Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis